AbbVie, Besins Owe $448M In FTC Androgel Antitrust Case
AbbVie Inc. and an affiliate must pay $448 million in the Federal Trade Commission's suit alleging they netted more than $1 billion after bringing sham patent lawsuits to stave off generic...To view the full article, register now.
Already a subscriber? Click here to view full article